Stock Updates

Today’s Top Gainers in the Market Edwards Lifesciences Corp. (NYSE:EW) from Healthcare

Today’s top gainers include the company Edwards Lifesciences Corp. (NYSE:EW) which is in the industry Medical Appliances & Equipment, gaining 2.31% today. In the last week its performance is -0.03%, and 10.79% for the past quarter. Currently, Edwards Lifesciences Corp., EW has a target price of 124.9, so today’s gain of 2.31% is a significant step towards its target price. The GAP today is therefore 0.86%.

Edwards Lifesciences Corp. (NYSE:EW), has a market cap of 25743.59, and is based in USA. Insider ownership is at 0.30%, and institutional ownership is 87.00%.

At the current price of 118.22, it has a dividend yield of *TBA, and its target price is 124.9. This is with a profit margin of 19.30%, and total debt/equity of 0.24. Edwards Lifesciences Corp. (NYSE:EW) has a P/E of 48.91, as well as a forward P/E of 34.55.

With a current EPS of 2.42, and a forecasted EPS growth for next year at 18.82%,Edwards Lifesciences Corp. (NYSE:EW) has had a EPS growth for the past five years at 19.70%. For the next five years EPS growth is projected to be 17.50%.

Performance for the year is 56.17%. Since its IPO date on 3/27/2000, the total performance to date is 49.68%.

Volume today for Edwards Lifesciences Corp. (NYSE:EW), is 1478800, while its average volume is 1173.86. Whilst the total gain today was 2.31%, it did have a day high of -2.90%.

Volatility for this week has been at 1.72%, and 1.69% for the month. The 52-week low for Edwards Lifesciences Corp., EW has been 63.74%, while the 52-week-high has reached -2.90%.

Looking at its return of investments, which is 15.90%, and its return on assets is 13.30%. Edwards Lifesciences Corp. (NYSE:EW) has an operating margin of 24.40%. With a sales growth of 23.10% quarter over quarter. Bearing in mind that Edwards Lifesciences Corp., EW is in the sector Healthcare, its long-term debt/equity is 0.24, and has a current ratio of 4.2 and 3.4 for quick ratio.

So what is the value of Edwards Lifesciences Corp.? Well its PEG is 2.8, and the P/S is 9.38, along with a P/B of 10.15. Meanwhile it has a p/cash of 24.28.

Disclaimer: Remember there is a risk to your investment, this is not a recommendation, nor personal advice, never invest more than you are able too loose.

About the author

Peter Clarke

Leave a Comment